£152.99

Medicare: Value-Based Care, Pharmacy Benefit Managers, Trust Fund Reports and Fee-For-Service (Health Care in Transition)

Health Issues

Price data last checked 75 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 16 days • 16 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 16 days • 1 price levels

Days at Price

Price Analysis

Most common price: £153 (16 days, 100.0%)

Price range: £153 - £153

Price levels: 1 different prices over 16 days

Description

Over the course of the last few years, our healthcare system has begun a shift toward rewarding physicians for the quality of care rather than the quantity, and building off these efforts, providers, doctors, health systems, and payers are willing to explore new value-based arrangements and open the door to providing new benefits for their beneficiaries. The Medicare Access and CHIP Reauthorization Act began to shift Medicare towards being a more value-based payment system. Chapter 1 discusses the models that are working toward improve the quality of care and reducing cost. Total expenditures for the Medicare Part D drug program exceeded $100 billion in 2016. Part D plan sponsors may use a pharmacy benefit manager (PBM) to provide drug benefit management services for Part D coverage, such as negotiating drug rebates and other price concessions and paying pharmacy claims. Policymakers have sought a better understanding of PBMs' roles in the drug supply chain and plans' and PBMs' efforts to manage Part D drug spending and use. Chapter 2 examines, (1) the extent to which Part D plan sponsors use PBMs, (2) trends in rebates and other price concessions obtained by both PBMs and plan sponsors for Part D drugs, and (3) how PBMs earn revenue for services provided to Part D plans. The Social Security Act requires boards of trustees to issue reports to Congress by April 1 each year on the financial status of the Social Security and Medicare trust funds. Chapter 3 (1) describes how the boards of trustees develop the annual Trustees reports, and (2) examines the extent to which the boards of trustees have provided the reports to Congress by the April 1 deadline, and what factors account for any delays. The Centers for Medicare & Medicaid Services (CMS) implemented a competitive bidding program (CBP) for certain durable medical equipment (DME), such as wheelchairs and oxygen. The Patient Protection and Affordable Care Act required CMS to adjust fee-for-service payment rates for certain DME items in non-bid areas. On January 1, 2016, adjusted rates for 393 items went into effect in non-bid areas. Chapter 4 examines (1) payment rate reductions and any changes in the number of suppliers; (2) any changes in the utilization of rate-adjusted items; and (3) available evidence related to potential changes in beneficiaries' access to rate-adjusted items.

Product Specifications

Format: Hardcover
ASIN: 1536174440
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues
Domain: Amazon UK
Release Date: 22 April 2020
Listed Since: 14 January 2020

Barcode

No barcode data available

Medicare: Value-Based Care, Pharmacy Benefit Managers, Trust Fund Reports and Fee-For-Service (Health Care in Transition)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Medicare, Health Care Delivery & Payment Reform Recommendations (Health Care Issues, Costs & Access Series) (Health Care Issues, Costs and Access)

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

Medicare Part B: Premiums & High-Expenditure Drugs (Health Care Issues, Costs and Access)

A Healthcare Solution: A Patient-Centered, Resource Management Perspective

Progress in Medical Research: Government Programs and Key Issues (Medical Procedures, Testing and Technology)

Pharmaceutical Public Policy

Cost-Based, Charge-Based, and Contractual Payment Systems (Healthcare Payment Systems)

Improving Medicare (Health Care Issues, Costs and Access)

Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)

Understanding Value Based Healthcare (MEDICAL/DENISTRY)

Pratt's Long-Term Care: Managing Across the Continuum

Improvements Needed in the VA Health Care System (Military and Veteran Issues: Health Care in Transition)

Medicare s Prescription Drug Program: Competition Issues & Cost Trends

MEDICARE HOME HEALTH BENEFIT: Elements & a Roadmap for Value-Based Incentive Payments (Health Care Issues, Costs and Access)

Defense Health Care: Treatment, Performance and TRICARE

The Health Care Safety Net in a Post-Reform World (Critical Issues in Health and Medicine)

Electronic Health Records: Overview, Challenges and Legislation

Health Insurance: Stabilizing Premiums, Effectiveness of the Individual Mandate and Expanding Services (Health Care in Transition)

Direct Pay: A Simpler Way to Practice Medicine

Health Care in the United States: Developments & Considerations -- Volume 6

Managed Entry Agreements and Funding for Expensive Therapies (Pharmaceuticals, Health Economics and Market Access)

Issues in Veterans' Health Care

Medicaid & Long-Term Care Assistance: Financial Eligibility Issues (Health Care in Transition)

Health Care in the United States: Developments and Considerations -- Volume 5